Cardiovascular devices are used in treating diseases related to the heart and the circulatory system. Cardiac catheters are narrow hollow tubes used for guiding and visualization of the coronary vasculature or the functioning of heart valves. GlobalData uses proprietary data and analytics to provide a comprehensive report on the cardiac catheters market in Japan. Buy the latest report here.

Smarter leaders trust GlobalData

In 2022, GlobalData’s Market Model methodology determined that the leading player in the cardiac catheters market in Japan was Asahi Intecc followed by B. Braun Melsungen, Boston Scientific, Cordis, Medtronic, Nipro, Teleflex and Terumo.

Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.

Cardiac catheters include guiding catheters and angiography catheters. Guiding catheters are catheters used to navigate stents and balloons during minimally invasive Percutaneous Coronary Interventions (PCIs). Through angiographic catheters a radio contrast dye is injected into the chambers of the heart for visualization of the vascular system which helps in detection of any abnormalities related to the coronary arteries or cardiac valves.

The cardiac catheters market in Japan can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.

For the latest analysis of the market size cardiac catheters in Japan, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.